Triethylenemelamine
Top View
- Analysis of Food and Drug Administration–Approved Anticancer Agents in the NCI60 Panel of Human Tumor Cell Lines
- TBD Noël J.-M. Raynal1, 2†, Justin T. Lee1, Gabriel Malouf2, Sarah
- Supplementary Material II. 579 Candidate Carcinogenic Chemicals, Their Betweenness and P-Values of Randomization Test
- United States Patent (10) Patent No.: US 8,173,177 B2 Dao Et Al
- C12) United States Patent (IO) Patent No.: US 9,777,013 B2 Nicolaou Et Al
- (12) United States Patent (10) Patent No.: US 9,512,107 B2 Cianchetta Et Al
- The Need for Additional Alkylating Agents and Antimetabolites
- Molecular Blueprints for Antitumor Drugs
- Mesh Terms for 2002
- NIH Public Access Author Manuscript J Nat Prod
- Ecological Soil Screening Levels for Cadmium Interim Final
- Predicting Synergism of Cancer Drug Combinations Using NCI-ALMANAC Data
- FIG. 16 WO 2015/006555 A2 Llll II II 11III II
- Chromosome Aberrations Induced in Human Leukocytes by the Antileukemic Antibiotic Adriamycin
- Antineoplastic Drugs